Dean Monti 2017-06-09 01:39:19
"The summit was a terrific opportunity to discuss important issues in health care that ultimately impact patients’ access to appropriate care." – Daren Sink, senior director, U.S. public affairs, U.S. government relations, Pfizer Inc. In Partnership In each issue, Aspire looks at how members of the corporate community are helping to advance and promote the mission of healthy skin, healthy lives. In this issue, we highlight the 6th annual AAD Industry Summit. There was much to discuss and take pride in when AAD and industry convened at the Langham Hotel in Chicago, March 30-31 for the 6th annual AAD Industry Summit presided over by C. William Hanke, MD, outgoing chair of the AAD Corporate Relations Committee. The Industry Summit provides industry and AAD leadership an opportunity for open discussion to identify issues confronting the AAD, its members, and industry that are of collective interest, as well as identifying potential solutions that ultimately benefit the patient. The two-day meeting, hosted by the AAD’s Corporate Relations Committee, was attended by 50 Academy leaders and industry representatives of the AAD’s Corporate Partner Circle in an ongoing and successful effort to continue a dialogue between the two. 1. Henry W. Lim, MD, AAD president, provided an overview of the Academy’s strategic priorities including “to continue the Academy’s mission as the unified voice of dermatology and expand the diversity in our profession.” 2. Presenters Brett M. Coldiron, MD, and Joel White, founder and president, Horizon Government Affairs, focused on health care reform during the Trump administration and discussed scenarios of how the ACA may be affected, depending on whether it is repealed or replaced. 3. The Academy’s leadership and representatives from companies in the Academy’s Corporate Partner Circle discuss the issues that affect the specialty and work together to create solutions that enhance quality patient care. New format, new issues for 2017 Efforts are made each year to improve upon and bring innovation to the format of the Industry Summit meetings. At the March 2017 Industry Summit, participating industry representatives were all given the unique opportunity — for the first time — to come to the microphone and talk about their company’s approach to the ever-changing health care environment and their specific challenges. Facilitated by Daniel M. Siegel, MD, MS, this new element of the Summit ensured that all industry voices were heard, and lively discussion ensued. Common among industry’s concerns were access to drugs, drug pricing, and educating residents about the treatments available for dermatologic diseases. Just a week prior to the meeting, the House’s first attempt to repeal and replace the Affordable Care Act (ACA) had failed, and the law’s immediate future remains in question. Joel White, founder and president of Horizon Government Affairs, presented information about why the ACA is difficult, if not impossible, to replace (though he believes it can be fixed and/or modified). White provided several plausible scenarios for the future of the ACA, but moreover, provided a greater understanding of what had led to the crisis in health care and trends that will continue into the next four years. Mark Lebwohl, MD, talked about restrictions on access to care. In 2016, Dr. Lebwohl led a successful effort to implement a prior authorization letter generator, now available at the AADA’s new Practice Management Center. The letters, created by dermatologists, are clinically specific for the top drugs used in dermatology today. AAD executive director and CEO, Elaine Weiss, JD, presented the new Practice Management Center on the second day of the Summit. She described the many Practice Management Center tools currently available to AAD members and what new elements are on the horizon. The Summit concluded with an agreed-upon determination that industry and AAD leaders will continue to work together to resolve the issues discussed and to further their collective mission to provide the best possible care to patients. 4. McKenzie Richards, manager of senior regional aesthetic marketing for Merz North America, Inc., reiterates a topic at the forefront of attendees’ minds by ensuring that residents are knowledgeable about available treatments for dermatologic diseases and conditions. 5. Daren Sink, senior director, U.S. public affairs, U.S. government relations, Pfizer Inc., provided an overview of how Pfizer views the challenges in today’s health care environment. 6. The summit was strategically topic-focused and provided an opportunity for industry, including Helen Kim Fitzpatrick, director, state government relations, Midwest region, and Patrick Gilha, director, federal government relations, Celgene Corporation, to share their approaches and solutions to benefit patient health.
Published by American Academy Of Dermatology. View All Articles.